Drug
Isis Crp RX
Isis Crp RX: highest development phase Phase 2, developed by Ionis Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ionis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ISIS CRP Rx NCT01710852 | Phase 2 | Paroxysmal Atrial Fibrillation |
Latest
No recent events.
Follow Isis Crp RX on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.